Tudor Investment Corp’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-236,649
| Closed | -$700K | – | 1500 |
|
|
2024
Q2 | $700K | Buy |
236,649
+145,915
| +161% | +$432K | ﹤0.01% | 1099 |
|
|
2024
Q1 | $411K | Buy |
+90,734
| New | +$411K | ﹤0.01% | 1151 |
|
|
2023
Q4 | – | Sell |
-20,105
| Closed | -$92.5K | – | 1416 |
|
|
2023
Q3 | $92.5K | Buy |
20,105
+1,858
| +10% | +$8.55K | ﹤0.01% | 1389 |
|
|
2023
Q2 | $118K | Buy |
18,247
+175
| +1% | +$1.13K | ﹤0.01% | 1420 |
|
|
2023
Q1 | $136K | Buy |
18,072
+2,424
| +15% | +$18.2K | ﹤0.01% | 1416 |
|
|
2022
Q4 | $159K | Buy |
15,648
+402
| +3% | +$4.09K | ﹤0.01% | 1393 |
|
|
2022
Q3 | $151K | Buy |
15,246
+4,977
| +48% | +$49.3K | ﹤0.01% | 1448 |
|
|
2022
Q2 | $109K | Sell |
10,269
-10,840
| -51% | -$115K | ﹤0.01% | 1443 |
|
|
2022
Q1 | $206K | Buy |
+21,109
| New | +$206K | ﹤0.01% | 1377 |
|
|
2021
Q4 | – | Sell |
-15,121
| Closed | -$303K | – | 1557 |
|
|
2021
Q3 | $303K | Sell |
15,121
-64,603
| -81% | -$1.29M | ﹤0.01% | 1309 |
|
|
2021
Q2 | $1.75M | Buy |
+79,724
| New | +$1.75M | 0.03% | 591 |
|